Prostate Cancer Therapeutics Market: Evolving Strategies for Improved Patient Care
Prostate cancer remains one of the most commonly diagnosed cancers among men, particularly in aging populations. Therapeutic approaches for this disease have evolved significantly over the years, moving beyond conventional hormone therapy to include advanced targeted treatments, immunotherapies, and precision medicine strategies. These developments are transforming how prostate cancer is managed across different stages.
Hormone-based therapies, which reduce or block androgen activity, have long been a foundational treatment for prostate cancer. While effective in early stages, resistance can develop over time, leading to more aggressive forms of the disease. This challenge has driven innovation toward next-generation androgen receptor inhibitors and combination therapies designed to delay disease progression.
Targeted therapies are gaining prominence in prostate cancer care. Treatments aimed at specific genetic mutations, such as DNA repair pathway alterations, are enabling more personalized treatment plans. Genetic testing and biomarker-driven decisions are helping identify patients who are most likely to benefit from…